AA,Alcoa to shut Sao Luis smelter in Brazil March 30 Aluminum maker Alcoa Inc said on Monday it would shut the remaining 74,000 metric tons of capacity at its Sao Luis smelter in Brazil due to weak metal prices and high costs. 
BA,EXCLUSIVE-Pentagon chief sends military wish lists to Congress with reservations WASHINGTON, March 30 U.S. Defense Secretary Ash Carter on Monday sent the military's annual "wish lists" to U.S. lawmakers, including 12 Boeing Co F/A-18 fighter jets and 14 Lockheed Martin Corp F-35 fighter jets, but said he would not back any of the requests unless Congress passed a larger overall defense budget. 
CVX,Australia shares tumble as commodities decline weighs on resources * Little upbeat economic data   (Adds analysis, quotes, stocks on the move) 
ESRX,Deals of the day- Mergers and acquisitionsUnitedHealth-Catamaran deal sets up healthcare M&A; chessboard NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.  UnitedHealth-Catamaran deal sets up healthcare M&A; chessboard NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up. March 30 The following bids, mergers, acquisitions and disposals were reported by 1400 GMT on Monday:UnitedHealth-Catamaran deal sets up healthcare M&A; chessboard NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.  
F,UPDATE 1-VW halts production for three weeks at Brazil plant - union SAO PAULO, March 30 Volkswagen AG  has furloughed 4,200 workers at its second largest factory in Brazil for three weeks, a local union said on Monday, as disappearing demand forces carmakers in the country to manage excess capacity. 
GM,GM's Cadillac CT6 tests strategy for taking fat out of big cars NEW YORK, March 30 When General Motors Co  takes the wraps off its new Cadillac CT6 on Tuesday the most important thing about the vehicle could be what is under its skin. 
GS,MOVES-Barclays, BofA Merrill, Deutsche Bank, Goldman Sachs March 30 The following financial services industry appointments were announced on Monday. To inform us of other job changes, email moves@thomsonreuters.com. 
HD,Amazon.com expands into professional services with home marketplace CHICAGO, March 30 Amazon.com Inc is launching a home services marketplace that will connect customers with electricians, plumbers and painters in a move to have its services tied to every product sold on its website. 
HUM,UnitedHealth-Catamaran deal sets up healthcare M&A; chessboard NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up. 
INTC,Europe Factors to Watch-Shares set to rise; techs in focusEuropean stocks bounce back, helped by techsRallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      PARIS, March 30 European stocks rose early on Monday, bouncing back from last week's losses with tech shares rallying after news of merger talks in the sector spurred a late-session rally on Wall Street on Friday.Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        European stocks bounce back, helped by techsRallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      PARIS, March 30 European stocks rose early on Monday, bouncing back from last week's losses with tech shares rallying after news of merger talks in the sector spurred a late-session rally on Wall Street on Friday.Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       PARIS, March 30 European stocks were set to rise on Monday, bouncing back from last week's losses with tech shares in focus after news of merger talks in the sector spurred a late-session rally on Wall Street on Friday.     Intel Corp is in talks to buy fellow chipmaker Altera Corp  in a deal likely to top $10 billion, according to a source familiar with the matter, which would make it Intel's biggest acquisition ever and the latest merger in the quickly consolidating semiconductor sEuropean stocks bounce back, helped by techsRallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      PARIS, March 30 European stocks rose early on Monday, bouncing back from last week's losses with tech shares rallying after news of merger talks in the sector spurred a late-session rally on Wall Street on Friday.Rallying techs help European stocks bounce backUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      US STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * Lafarge drops as two Holcim shareholders reject revised dealUS STOCKS-Futures higher, but crude oil weakensUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     US STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Futures point to higher open on M&A; activityUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   * M&A; deal lifts sentiment; UnitedHealth unit to buy CatamaranUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        
JNJ,J&J;, Glaxo settle U.S. lawsuit over allergy adsJ&J;, Glaxo settle U.S. lawsuit over allergy ads NEW YORK GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share.  J&J;, Glaxo settle U.S. lawsuit over allergy ads NEW YORK GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share. NEW YORK, March 30 GlaxoSmithKline Plc  has agreed to settle a lawsuit by Johnson & Johnson  accusing it of using false advertising at the start of the U.S. allergy season to grab market share.J&J;, Glaxo settle U.S. lawsuit over allergy ads NEW YORK GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share.  
LMT,UPDATE 1-S.Korea picks KAI, with Lockheed, for $7.9 bln fighter jet development * North Korea's missile capabilities a key concern   (Updates throughout with DAPA comment, KF-X programme details, S.Korea arms budget) 
LOW,Amazon.com expands into professional services with home marketplace CHICAGO, March 30 Amazon.com Inc is launching a home services marketplace that will connect customers with electricians, plumbers and painters in a move to have its services tied to every product sold on its website. 
MCD,McDonald's starts table service in GermanyUPDATE 2-McDonald's starts table service in Germany FRANKFURT, March 30 McDonald's Corp is introducing table service in Germany as it reinvents itself as a "modern, progressive burger company" under new Chief Executive Steve Easterbrook.  UPDATE 2-McDonald's starts table service in Germany FRANKFURT, March 30 McDonald's Corp is introducing table service in Germany as it reinvents itself as a "modern, progressive burger company" under new Chief Executive Steve Easterbrook. FRANKFURT, March 30 McDonald's Corp is introducing table service in Germany as it reinvents itself as a "modern, progressive burger company" under new Chief Executive Steve Easterbrook, it said on Monday.UPDATE 2-McDonald's starts table service in Germany FRANKFURT, March 30 McDonald's Corp is introducing table service in Germany as it reinvents itself as a "modern, progressive burger company" under new Chief Executive Steve Easterbrook.  
RL,Ralph Lauren to get $3.2 mln from Indian licensee Arvind in settlementRalph Lauren to get $3.2 million from Indian licensee Arvind in settlementRalph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.   Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Textile maker Arvind Ltd said on Monday its lifestyle brands subsidiary would pay $3.2 million to Ralph Lauren to settle a lawsuit the US-based luxury fashion house filed in 2013.Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.    Ralph Lauren to get $3.2 million from Indian licensee Arvind in settlementRalph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.   Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Textile maker Arvind Ltd said on Monday its lifestyle brands subsidiary would pay $3.2 million to Ralph Lauren to settle a lawsuit the US-based luxury fashion house filed in 2013.Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.   March 30 Textile maker Arvind Ltd said on Monday its lifestyle brands subsidiary would pay $3.2 million to Ralph Lauren to settle a lawsuit the US-based luxury fashion house filed in 2013.Ralph Lauren to get $3.2 million from Indian licensee Arvind in settlementRalph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.   Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Textile maker Arvind Ltd said on Monday its lifestyle brands subsidiary would pay $3.2 million to Ralph Lauren to settle a lawsuit the US-based luxury fashion house filed in 2013.Ralph Lauren can pursue contempt claim over polo player logoRalph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.  Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration. NEW YORK, March 30 A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.Ralph Lauren can pursue contempt claim over polo player logo NEW YORK A Manhattan federal judge said Ralph Lauren Corp may try to hold the U.S. Polo Association in contempt for using a logo that resembles its iconic polo player logo, but put the case on hold for a related arbitration.    
CRM,Europe Factors to Watch-Shares set to rise; techs in focus PARIS, March 30 European stocks were set to rise on Monday, bouncing back from last week's losses with tech shares in focus after news of merger talks in the sector spurred a late-session rally on Wall Street on Friday.     Intel Corp is in talks to buy fellow chipmaker Altera Corp  in a deal likely to top $10 billion, according to a source familiar with the matter, which would make it Intel's biggest acquisition ever and the latest merger in the quickly consolidating semiconductor s 
MOS,Canpotex sets potash contracts with Chinese buyersUPDATE 1-Canpotex sets potash contracts with Chinese buyers WINNIPEG, Manitoba, March 30 Canpotex Ltd, the offshore potash sales arm of North America's Potash Corp of Saskatchewan , Mosaic Co and Agrium Inc , said on Monday it had set 2015 supply contracts with major Chinese buyers, including Sinofert Holdings Ltd, and expected higher volume.  UPDATE 1-Canpotex sets potash contracts with Chinese buyers WINNIPEG, Manitoba, March 30 Canpotex Ltd, the offshore potash sales arm of North America's Potash Corp of Saskatchewan , Mosaic Co and Agrium Inc , said on Monday it had set 2015 supply contracts with major Chinese buyers, including Sinofert Holdings Ltd, and expected higher volume. WINNIPEG, Manitoba, March 30 Canpotex Ltd, the offshore potash sales arm of Potash Corp of Saskatchewan  , Mosaic Co and Agrium Inc, said on Monday it had set 2015 supply contracts with major Chinese buyers, including Sinofert Holdings Ltd.UPDATE 1-Canpotex sets potash contracts with Chinese buyers WINNIPEG, Manitoba, March 30 Canpotex Ltd, the offshore potash sales arm of North America's Potash Corp of Saskatchewan , Mosaic Co and Agrium Inc , said on Monday it had set 2015 supply contracts with major Chinese buyers, including Sinofert Holdings Ltd, and expected higher volume.  
UNH,Deals of the day- Mergers and acquisitionsCANADA STOCKS-Bank, Catamaran shares drive TSX higherUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       TORONTO, March 30 Canada's main stock index climbed on Monday, supported by advances in the financial sector and a jump in Catamaran Corp after UnitedHealth Group Inc agreed to buy the pharmacy benefit manager. .US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline         CANADA STOCKS-Bank, Catamaran shares drive TSX higherUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       TORONTO, March 30 Canada's main stock index climbed on Monday, supported by advances in the financial sector and a jump in Catamaran Corp after UnitedHealth Group Inc agreed to buy the pharmacy benefit manager. .US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        March 30 The following bids, mergers, acquisitions and disposals were reported by 1400 GMT on Monday:CANADA STOCKS-Bank, Catamaran shares drive TSX higherUS STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline        US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       TORONTO, March 30 Canada's main stock index climbed on Monday, supported by advances in the financial sector and a jump in Catamaran Corp after UnitedHealth Group Inc agreed to buy the pharmacy benefit manager. .US STOCKS-Wall St higher as biotechs rally on M&A; dealsUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline       US STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      * M&A; deal lifts sentiment; biotech coming off big weekly declineUS STOCKS-Wall St bounces back from recent losses; deals helpUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline      UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     * M&A; deal lifts sentiment; biotech coming off big weekly declineUPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 blnUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline     UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    March 30 Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline    UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   NEW YORK, March 30 UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth-Catamaran deal sets up healthcare M&A; chessboardUnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline   UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  NEW YORK UnitedHealth Group Inc's  planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp  will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billionUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline Health insurer UnitedHealth Group Inc  agreed to buy Catamaran Corp  in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . | US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline VideoUS STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline  US STOCKS-Wall St rebounds from recent losses; deals help * M&A; deal lifts sentiment; biotech coming off big weekly decline         
WMT,UPDATE 2-GNC Holdings settles herbal supplements dispute with NY Attorney GeneralSEC says Wal-Mart can omit shareholder proposal on staff 'engagement'SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.  SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor. March 30 Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.   SEC says Wal-Mart can omit shareholder proposal on staff 'engagement'SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.  SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor. March 30 Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.  * NY AG test also confirms GNC's products meet FDA guidelinesSEC says Wal-Mart can omit shareholder proposal on staff 'engagement'SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.  SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor. March 30 Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.SEC says Wal-Mart can omit shareholder proposal on staff 'engagement' Wal-Mart Stores Inc said it would omit a shareholder proposal that sought to link executive pay to a measure of staff motivation from a vote at its annual meeting in June after the U.S. securities regulator ruled in the retailer's favor.   
